128 related articles for article (PubMed ID: 31924714)
1. Disparity in implantable cardioverter defibrillator therapy among minority South Asians in the United Kingdom.
Mistry A; Vali Z; Sidhu B; Budgeon C; Yuyun MF; Pooranachandran V; Li X; Newton M; Watts J; Khunti K; Samani NJ; Ng GA
Heart; 2020 May; 106(9):671-676. PubMed ID: 31924714
[TBL] [Abstract][Full Text] [Related]
2. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
[TBL] [Abstract][Full Text] [Related]
3. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
[TBL] [Abstract][Full Text] [Related]
4. Evidence for reduced susceptibility to cardiac bradycardias in South Asians compared with Caucasians.
Yuyun MF; Squire IB; Ng GA; Samani NJ
Heart; 2018 Aug; 104(16):1350-1355. PubMed ID: 29463611
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
6. Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure.
Chia YMF; Teng TK; Tan ESJ; Tay WT; Richards AM; Chin CWL; Shimizu W; Park SW; Hung CL; Ling LH; Ngarmukos T; Omar R; Siswanto BB; Narasimhan C; Reyes EB; Yu CM; Anand I; MacDonald MR; Yap J; Zhang S; Finkelstein EA; Lam CSP
Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29150533
[TBL] [Abstract][Full Text] [Related]
7. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.
Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS
Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233
[TBL] [Abstract][Full Text] [Related]
8. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
[TBL] [Abstract][Full Text] [Related]
9. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
10. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
11. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
[TBL] [Abstract][Full Text] [Related]
12. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
[TBL] [Abstract][Full Text] [Related]
14. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.
Leshem E; Suleiman M; Laish-Farkash A; Konstantino Y; Glikson M; Barsheshet A; Goldenberg I; Michowitz Y;
Europace; 2017 Sep; 19(9):1485-1492. PubMed ID: 27702848
[TBL] [Abstract][Full Text] [Related]
15. Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
Fauchier L; Marijon E; Defaye P; Piot O; Sadoul N; Perier MC; Gras D; Klug D; Algalarrondo V; Bordachar P; Deharo JC; Leclercq C; Babuty D; Boveda S;
Am J Cardiol; 2015 May; 115(10):1415-22. PubMed ID: 25784518
[TBL] [Abstract][Full Text] [Related]
16. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
